Skip to main content
SkinCited

Vitamin D per Psoriasis

B Evidenze Almeno un trial randomizzato lo supporta, con risultati per lo più coerenti.

Vitamin D deficiency is significantly associated with increased psoriasis severity. Research suggests supplementation (1,000-4,000 IU/day) may support skin immune regulation via vitamin D receptor-mediated keratinocyte differentiation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'skincited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dpsoriasis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

In sintesi

Vitamin D deficiency is significantly associated with increased psoriasis severity. Research suggests supplementation (1,000-4,000 IU/day) may support skin immune regulation via vitamin D receptor-mediated keratinocyte differentiation.

Key Study Findings

Observational Study n=573
Vitiligo: Clinical and Laboratory Characteristics in 573 Saudi Patients.
Dose: None vs: None Outcome: Vitiligo prevalence and clinical characteristics Effetto: None None

Popolazione: Saudi patients with vitiligo (573)

retrospective observational with Mendelian randomization
Association of vitamin D with risk of warts: A retrospective and Mendelian randomization study.
Dose: None vs: Placebo Effetto: OR 1.86 (95% CI 1.19-2.92) 0.007
Review
Nutritional Supplements for Skin Health-A Review of What Should Be Chosen and Why.
Dose: 14 nutritional compounds (vitamins, minerals, etc.) vs: None Outcome: Skin health and barrier function Effetto: None None

Popolazione: General population (skin health review)

Review
[Not Available].
Dose: None vs: None Outcome: body weight/composition Effetto: None None

Popolazione: Coeliac disease or merely presence of coeliac-specific antibodies

Review
The Role of VD/VDR Signaling Pathway in Autoimmune Skin Diseases.
Dose: None vs: None Outcome: hair regrowth Effetto: None None

Popolazione: None

Other n=332984
Associations between vitamin D and autoimmune diseases: Mendelian randomization analysis.
Dose: Vitamin D (25OHD, genetically predicted) vs: Genetic instrument comparison Outcome: Autoimmune disease risk Effetto: None None

Popolazione: UK Biobank participants (332,984)

Key Statistics

16

Studi

2200

Partecipanti

Positive

B

Grado

Referenced Papers

Ugeskrift for laeger 2023
Dermatologic therapy 2022 42 citazioni
Journal of the … 2020 57 citazioni
American journal of … 2018 138 citazioni
Clinics in dermatology 2016 19 citazioni
Journal of the … 2014 93 citazioni
Journal of cutaneous … 2014 35 citazioni
American family physician 2006

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
600-800 IU/day (RDA)
skinhealth:
1,000-4,000 IU/day (targeting 30-50 ng/mL serum 25(OH)D)

Limite massimo: 4,000 IU/day (IOM); many experts consider up to 10,000 IU/day safe

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Neutral 573
None -- Mixed --
14 nutritional compounds (vitamins, minerals, etc.) -- Positive --
None -- Positive --
None -- Mixed --
Vitamin D (25OHD, genetically predicted) -- Positive 332984
None -- Positive --
2000 IU/day vitamin D + 1g/day omega-3 260 weeks Positive 25871

Momento migliore per l'assunzione: With meals containing fat for better absorption

Safety & Side Effects

Effetti collaterali segnalati

  • Generally well-tolerated at recommended doses
  • Hypercalcemia at very high doses (nausea, vomiting, weakness)
  • Kidney stones (rare, at excessive doses)

Interazioni note

  • Thiazide diuretics (may increase calcium levels)
  • Corticosteroids (may reduce vitamin D absorption)
  • Orlistat and cholestyramine (reduce absorption of fat-soluble vitamins)
  • Calcipotriene (additive vitamin D effect)

Livello di assunzione massimo tollerabile: 4,000 IU/day (IOM); many experts consider up to 10,000 IU/day safe

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Vitamin D help with Psoriasis?
Based on 16 studies with 2,200 participants, there is moderate evidence from clinical studies that Vitamin D may support Psoriasis management. Our evidence grade is B (Good Evidence).
How much Vitamin D should I take for Psoriasis?
Studies have used various dosages. A commonly studied range is 600-800 IU/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Generally well-tolerated at recommended doses, Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones (rare, at excessive doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Psoriasis?
We rate the evidence as Grade B (Good Evidence). This rating is based on 16 peer-reviewed studies with 2,200 total participants. The overall direction of effect is positive.

Altri ingredienti per Psoriasis

Vitamin D per altre condizioni

References

  1. [1] Mohammed Ibrahim AlJasser. Clin Cosmet Investig Dermatol. 2024. Vitiligo: Clinical and Laboratory Characteristics in 573 Saudi Patients. doi:10.2147/CCID.S499794 PubMed
  2. [2] Yuting Cao et al.. Skin Res Technol. 2024. Association of vitamin D with risk of warts: A retrospective and Mendelian randomization study. doi:10.1111/srt.13911 PubMed
  3. [3] Jacek Januszewski et al.. Medicina (Kaunas). 2023. Nutritional Supplements for Skin Health-A Review of What Should Be Chosen and Why. doi:10.3390/medicina60010068 PubMed
  4. [4] Sizheng Steven Zhao et al.. Semin Arthritis Rheum. 2023. Associations between vitamin D and autoimmune diseases: Mendelian randomization analysis. doi:10.1016/j.semarthrit.2023.152238 PubMed
  5. [5] Yilan Zeng et al.. Mini Rev Med Chem. 2023. The Role of VD/VDR Signaling Pathway in Autoimmune Skin Diseases. doi:10.2174/1389557523666221124123206 PubMed
  6. [6] Charlotte Näslund-Koch et al.. Ugeskr Laeger. 2023. [Not Available]. PubMed
  7. [7] Jill Hahn et al.. BMJ. 2022. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. doi:10.1136/bmj-2021-066452 PubMed
  8. [8] Sofia Nogueira et al.. Dermatol Ther. 2022. Tapinarof for the treatment of psoriasis. doi:10.1111/dth.15931 PubMed
  9. [9] R Z Conic et al.. J Eur Acad Dermatol Venereol. 2020. Comorbidities in pediatric alopecia areata. doi:10.1111/jdv.16727 PubMed
  10. [10] Elio Kechichian et al.. Am J Clin Dermatol. 2018. Vitamin D and the Skin: An Update for Dermatologists. doi:10.1007/s40257-017-0323-8 PubMed
  11. [11] Meagen McCusker et al.. Clin Dermatol. 2016. Nutrition and skin: Kids are not just little people. doi:10.1016/j.clindermatol.2016.07.004 PubMed
  12. [12] Jillian W Millsop et al.. J Am Acad Dermatol. 2014. Diet and psoriasis, part III: role of nutritional supplements. doi:10.1016/j.jaad.2014.03.016 PubMed
  13. [13] Heidi Wat et al.. J Cutan Med Surg. 2014. Off-label uses of topical vitamin D in dermatology: a systematic review. doi:10.2310/7750.2013.13109 PubMed
  14. [14] Michael P Pender. Autoimmune Dis. 2012. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis. doi:10.1155/2012/189096 PubMed
  15. [15] Kelly M Luba et al.. Am Fam Physician. 2006. Chronic plaque psoriasis. PubMed

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.